A detailed history of Groupama Asset Managment transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Groupama Asset Managment holds 96,084 shares of BMRN stock, worth $6.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
96,084
Previous 95,601 0.51%
Holding current value
$6.1 Million
Previous $7.87 Billion 31.11%
% of portfolio
0.14%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$69.02 - $93.84 $33,336 - $45,324
483 Added 0.51%
96,084 $5.42 Billion
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $96,014 - $118,963
1,290 Added 1.37%
95,601 $7.87 Billion
Q1 2024

May 14, 2024

SELL
$83.81 - $99.0 $539,904 - $637,758
-6,442 Reduced 6.39%
94,311 $9.37 Billion
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $7.68 Million - $9.93 Million
100,753 New
100,753 $9.72 Billion

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.